コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tibody escape data from horses infected with equine infectious anemia virus.
2 Ponies were infected with equine infectious anemia virus.
3 g the properties of the LYPDL late domain of equine infectious anemia virus.
4 y against N-tropic murine leukemia virus and equine infectious anemia virus.
5 during experimental infection of ponies with equine infectious anemia virus.
6 sease in ponies experimentally infected with equine infectious anemia virus.
7 transcriptases of human immunodeficiency and equine infectious anemia viruses.
8 Previous pre-steady-state kinetic studies of equine infectious anemia virus-1 (EIAV) reverse transcri
10 CDs of HIV-2, bovine immunodeficiency virus, equine infectious anemia virus, and feline immunodeficie
13 the prototype YPDL-type L domain encoded by equine infectious anemia virus (EIAV) acts by recruiting
14 atypical NES-containing Rev-like proteins of equine infectious anemia virus (EIAV) and feline immunod
18 ruses is disrupted by proteasome inhibitors, equine infectious anemia virus (EIAV) budding is not aff
20 immunodeficiency virus type one (HIV-1) and equine infectious anemia virus (EIAV) capsid proteins, a
23 repeat (LTR) of macrophage-tropic strains of equine infectious anemia virus (EIAV) contains three PU.
24 molecular clones pSPeiav19 and p19/wenv17 of equine infectious anemia virus (EIAV) differ in env and
25 current study examined the entry pathway of equine infectious anemia virus (EIAV) during infection o
27 thesis directly, we examined the patterns of equine infectious anemia virus (EIAV) envelope variation
29 ssays with transfected cells reveal that the equine infectious anemia virus (EIAV) Gag p9 protein pro
31 f three functionally distinct regions of the equine infectious anemia virus (EIAV) genome (env, rev,
33 sly that a lentiviral vector system based on equine infectious anemia virus (EIAV) gives rise to high
34 t (LTR) sequence variation of the lentivirus equine infectious anemia virus (EIAV) has not been explo
36 recombinant p26 capsid protein (CA) from the equine infectious anemia virus (EIAV) have in common an
37 share common assembly mechanisms, studies of equine infectious anemia virus (EIAV) have indicated alt
38 whole-virus and envelope subunit vaccines to equine infectious anemia virus (EIAV) have revealed a br
41 f N-tropic murine leukemia virus (N-MLV) and equine infectious anemia virus (EIAV) infection, promoti
43 tudies have demonstrated that the lentivirus equine infectious anemia virus (EIAV) infects tissue mac
48 usly demonstrated that the Gag p9 protein of equine infectious anemia virus (EIAV) is functionally ho
52 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV) L domain-derived p
53 e have identified an interaction between the equine infectious anemia virus (EIAV) late assembly doma
54 n for human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) lentiviral vectors
56 gomerization of the naturally unmyristylated equine infectious anemia virus (EIAV) MA and its interac
57 asma from a horse persistently infected with equine infectious anemia virus (EIAV) neutralized homolo
64 ncy virus (BIV), maedi-visna virus (MVV) and equine infectious anemia virus (EIAV) readily interacted
65 brain and another data set consisting of the equine infectious anemia virus (EIAV) regulatory gene re
67 export of incompletely spliced viral mRNAs, equine infectious anemia virus (EIAV) Rev regulates alte
69 t serial truncation of the Gag p9 protein of equine infectious anemia virus (EIAV) revealed a progres
71 mmunodeficiency virus mac239 (SIVmac239) and equine infectious anemia virus (EIAV) the most dependent
74 in budding assays that the Gag p9 protein of equine infectious anemia virus (EIAV) utilizes a unique
76 s nonpathogenic molecular clone (19-2-6A) of equine infectious anemia virus (EIAV) was modified by su
77 g the Gag/Pr or SU protein of the lentivirus equine infectious anemia virus (EIAV) were constructed a
78 n we studied the full-length CA protein from equine infectious anemia virus (EIAV), a lentivirus shar
80 efficacious subunit peptide vaccine against equine infectious anemia virus (EIAV), a naturally occur
82 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV), and inhibits the
83 an experimental live attenuated vaccine for equine infectious anemia virus (EIAV), based on mutation
85 iruses, the ungulate lentiviruses, including equine infectious anemia virus (EIAV), exclusively infec
86 (SIV), bovine immunodeficiency virus (BIV), equine infectious anemia virus (EIAV), feline immunodefi
87 Control of a naturally occurring lentivirus, equine infectious anemia virus (EIAV), occurs in most in
88 HIV-1, feline immunodeficiency virus (FIV), equine infectious anemia virus (EIAV), or N-tropic murin
100 s of adeno-associated virus 2 (AAV2)/GDNF or equine infectious anemia virus (EIAV)/GDNF into the caud
101 human immunodeficiency virus type 1 [HIV-1], equine infectious anemia virus [EIAV]) and unrestricted
102 lentiviruses, including HIV-1 (but excluding equine infectious anemia virus), encode a viral infectiv
105 vators (Tat) from human immunodeficiency and equine infectious anemia viruses (HIV and EIAV) interact
107 e association of Alix 364-716 with HIV-1 and equine infectious anemia virus late domains was quantita
109 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus particle production.
110 -independent budding previously observed for equine infectious anemia virus (plasma membrane assembly
111 tical for control of lentiviruses, including equine infectious anemia virus, relatively little is kno
112 human T-cell leukemia virus type 1 Rex, and equine infectious anemia virus Rev but not with function
113 two nonprimate lentiviruses, visna virus and equine infectious anemia virus, revealed that their acti
114 s supported by the 66 and 51 kDa subunits of equine infectious anemia virus reverse transcriptase (EI
115 echanism underlying this event, catalyzed by equine infectious anemia virus reverse transcriptase (EI
117 nstrated that pseudotyping of the nonprimate equine infectious anemia virus (using the lentivector ge
118 ed that a successful experimental attenuated equine infectious anemia virus vaccine, derived by mutat
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。